marketcaparena
Search

    SRZN

    Surrozen, Inc./DE

    Company overview

    Market capitalization
    $348.38M
    Employees
    44
    Latest publication
    2026-09-29
    About Surrozen, Inc./DE

    Surrozen, Inc., a biotechnology company, discovers and develops product candidates to selectively modulate the Wnt pathway for tissue repair. Its lead product candidates are antibody-based therapeutics that target various disease areas, including diseases of the eye, intestine, liver, lung, retina, kidney, cochlea, cornea, skin, pancreas, and central nervous system. The company develops SZN-814, which combines Frizzled 4 (Fzd4 agonism) and vascular endothelial growth factor (VEGF antagonism) to treat diabetic macular edema (DME), neovascular age-related macular degeneration (wet AMD), and retinopathy indications; SZN-8143, which combines Fzd4 agonism, VEGF antagonism, and interleukin-6, or IL-6 for the treatment of DME/wet AMD/uveitic macular edema; and SZN-413, a Fzd4 targeted bi-specific antibody for the treatment of retinal vascular associated diseases. Surrozen, Inc. has a collaboration and license agreement with Boehringer Ingelheim International GmbH to research, develop, and commercialize Fzd4 bi-specific antibodies; and a research collaboration agreement with TCGFB, Inc. to discover antibody therapeutics targeting transforming growth factor beta, or TGF-ß, for the treatment of patients with idiopathic pulmonary fibrosis. Surrozen, Inc. was founded in 2015 and is headquartered in South San Francisco, California.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Total Revenue5,000,000USD528,000USD983,000USD983,000USD983,000USD655,000USD10,000,000USD0USD
    Cost Of Revenue65,000USD45,000USD—137,000USD—322,000USD342,000USD386,000USD
    Gross Profit4,935,000USD528,000USD983,000USD983,000USD983,000USD655,000USD10,000,000USD-386,000USD
    Research Development9,328,000USD8,991,000USD7,774,000USD6,042,000USD6,558,000USD5,350,000USD5,200,000USD4,949,000USD
    Selling General Administrative6,128,000USD4,176,000USD4,094,000USD3,958,000USD3,976,000USD3,897,000USD3,568,000USD3,714,000USD
    Total Operating Expenses15,391,000USD13,167,000USD11,868,000USD10,000,000USD10,534,000USD9,247,000USD8,768,000USD8,663,000USD
    Operating Income-10,456,000USD-12,639,000USD-10,885,000USD-9,017,000USD-9,551,000USD-8,592,000USD1,232,000USD-9,049,000USD
    Interest Income912,000USD788,000USD911,000USD1,025,000USD296,000USD387,000USD431,000USD490,000USD
    Net Interest Income912,000USD788,000USD911,000USD1,025,000USD296,000USD387,000USD431,000USD490,000USD
    Income Before Tax-127,505,000USD-183,159,000USD-71,643,000USD39,746,000USD-26,970,000USD-28,039,000USD-1,434,000USD-25,261,000USD
    Net Income-127,505,000USD-183,159,000USD-71,643,000USD39,746,000USD-26,970,000USD-28,039,000USD-1,434,000USD-25,261,000USD
    Net Income From Continuing Ops-127,505,000USD-183,159,000USD-71,643,000USD39,746,000USD-26,970,000USD-28,039,000USD-1,434,000USD-25,261,000USD
    Ebit-10,456,000USD-12,639,000USD-71,643,000USD-9,017,000USD-9,551,000USD-8,592,000USD1,232,000USD-9,049,000USD
    Ebitda-10,391,000USD-12,594,000USD-71,582,000USD-8,880,000USD-9,257,000USD-8,270,000USD1,574,000USD-8,663,000USD
    Depreciation And Amortization65,000USD45,000USD61,000USD137,000USD294,000USD322,000USD342,000USD386,000USD
    Reconciled Depreciation65,000USD45,000USD61,000USD137,000USD294,000USD322,000USD342,000USD386,000USD
    Total Other Income Expense Net-117,049,000USD-170,520,000USD-60,758,000USD48,763,000USD-17,419,000USD-19,447,000USD-2,666,000USD-16,212,000USD
    Interest Expense—————1,693,000USD——
    Income Tax Expense—————-348,724USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USD
    Total Revenue3,477,000USD10,655,000USD12,500,000USD12,500,000USD0USD0USD—
    Cost Of Revenue537,000USD1,442,000USD27,230,000USD3,269,000USD3,297,000USD2,929,000USD—
    Gross Profit2,940,000USD10,655,000USD-27,230,000USD12,500,000USD-3,297,000USD-2,929,000USD—
    Research Development29,365,000USD21,132,000USD27,230,000USD37,013,000USD40,177,000USD25,684,000USD19,603,000USD
    Selling General Administrative16,204,000USD15,062,000USD15,798,000USD19,826,000USD14,214,000USD7,123,000USD5,503,000USD
    Total Operating Expenses45,032,000USD36,194,000USD18,550,000USD56,839,000USD54,391,000USD29,878,000USD24,806,000USD
    Operating Income-42,092,000USD-25,539,000USD-45,780,000USD-44,339,000USD-54,391,000USD-32,807,000USD-25,106,000USD
    Interest Income3,020,000USD1,693,000USD2,305,000USD781,000USD72,000USD91,000USD—
    Net Interest Income3,020,000USD1,693,000USD2,305,000USD781,000USD72,000USD91,000USD—
    Income Before Tax-242,026,000USD-63,564,000USD-43,042,000USD-36,004,000USD-54,648,000USD-32,716,000USD-24,362,000USD
    Net Income-242,026,000USD-63,564,000USD-43,042,000USD-27,669,000USD-52,510,000USD-32,625,000USD-24,362,000USD
    Net Income From Continuing Ops-242,026,000USD-63,564,000USD-34,904,000USD-36,004,000USD-54,648,000USD-32,716,000USD—
    Ebit-42,092,000USD-25,539,000USD-43,042,000USD-44,339,000USD-54,391,000USD-34,297,945USD-25,106,000USD
    Ebitda-41,555,000USD-24,097,000USD-41,131,000USD-42,384,000USD-52,325,000USD-31,368,945USD-22,823,000USD
    Depreciation And Amortization537,000USD1,442,000USD1,911,000USD1,955,000USD2,066,000USD2,929,000USD2,283,000USD
    Reconciled Depreciation537,000USD1,442,000USD1,938,000USD1,955,000USD2,066,000USD1,937,000USD—
    Total Other Income Expense Net-199,934,000USD-38,025,000USD2,738,000USD8,335,000USD-257,000USD91,000USD744,000USD
    Income Tax Expense—-63,564,000USD2,752,000USD-8,335,000USD-2,138,000USD-91,000USD—
    Unclassified Operating Expenses——-24,478,000USD——-2,929,000USD—
    Interest Expense———1,955,000USD2,066,000USD91,000USD0USD
    Net Income Applicable To Common Shares————-54,648,000USD-32,716,000USD-24,362,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Total Assets120,709,000USD98,726,000USD94,046,000USD102,696,000USD114,829,000USD48,467,000USD47,998,000USD45,071,000USD
    Other Current Assets2,039,000USD2,106,000USD1,957,000USD1,276,000USD1,734,000USD1,826,000USD2,078,000USD1,760,000USD
    Total Liab398,856,000USD286,488,000USD117,561,000USD55,582,000USD109,155,000USD69,847,000USD42,331,000USD39,009,000USD
    Total Stockholder Equity-278,147,000USD-187,762,000USD-23,515,000USD47,114,000USD5,674,000USD-21,380,000USD5,667,000USD6,062,000USD
    Other Current Liab6,749,000USD7,912,000USD4,746,000USD4,191,000USD9,090,000USD5,180,000USD4,317,000USD3,644,000USD
    Common Stock1,000USD1,000USD1,000USD1,000USD1,000USD———
    Capital Stock1,000USD1,000USD1,000USD1,000USD1,000USD0USD0USD0USD
    Retained Earnings-654,790,000USD-527,285,000USD-344,126,000USD-272,483,000USD-312,229,000USD-285,259,000USD-257,220,000USD-255,786,000USD
    Cash106,910,000USD89,245,000USD81,335,000USD90,390,000USD101,645,000USD34,565,000USD31,012,000USD37,765,000USD
    Cash And Short Term Investments106,910,000USD89,245,000USD81,335,000USD90,390,000USD101,645,000USD34,565,000USD31,012,000USD37,765,000USD
    Total Current Assets113,949,000USD91,559,000USD85,860,000USD94,235,000USD106,011,000USD38,932,000USD45,286,000USD41,637,000USD
    Total Current Liabilities9,565,000USD9,930,000USD6,528,000USD5,743,000USD10,582,000USD7,315,000USD6,120,000USD5,983,000USD
    Net Debt-100,132,000USD-82,606,000USD-74,253,000USD-82,876,000USD-93,677,000USD-26,096,000USD-29,485,000USD-35,599,000USD
    Short Term Debt1,927,000USD1,290,000USD1,244,000USD1,198,000USD1,190,000USD1,829,000USD1,527,000USD2,166,000USD
    Short Long Term Debt Total6,778,000USD6,639,000USD7,082,000USD7,514,000USD7,968,000USD8,469,000USD1,527,000USD2,166,000USD
    Net Receivables5,000,000USD208,000USD2,568,000USD2,569,000USD2,632,000USD2,541,000USD12,196,000USD2,112,000USD
    Accounts Payable889,000USD728,000USD538,000USD354,000USD302,000USD306,000USD276,000USD173,000USD
    Property Plant Equipment Net6,038,000USD6,433,000USD6,589,000USD7,076,000USD7,645,000USD8,363,000USD1,673,000USD2,373,000USD
    Property Plant Equipment Gross6,038,000USD14,808,000USD6,589,000USD7,076,000USD7,645,000USD16,210,000USD1,673,000USD2,373,000USD
    Common Stock Shares Outstanding10,949,000shares9,098,807shares8,571,000shares8,541,000shares3,628,000shares3,262,000shares3,228,000shares3,162,000shares
    Non Current Assets Total6,760,000USD7,167,000USD8,186,000USD8,461,000USD8,818,000USD9,535,000USD2,712,000USD3,434,000USD
    Non Current Liabilities Total389,291,000USD276,558,000USD111,033,000USD49,839,000USD98,573,000USD62,532,000USD36,211,000USD33,026,000USD
    Non Current Liabilities Other235,517,000USD158,662,000USD51,651,000USD10,903,000USD42,423,000USD———
    Non Currrent Assets Other722,000USD46,000USD1,597,000USD1,385,000USD101,000USD1,172,000USD1,039,000USD373,000USD
    Net Working Capital104,384,000USD81,629,000USD79,332,000USD88,492,000USD95,429,000USD31,617,000USD39,166,000USD35,654,000USD
    Unclassified Non Current Liabilities153,774,000USD117,896,000USD59,382,000USD38,936,000USD56,150,000USD62,532,000USD36,211,000USD33,026,000USD
    Unclassified Equity376,641,000USD339,521,000USD320,609,000USD319,595,000USD317,901,000USD263,879,000USD262,887,000USD261,848,000USD
    Accumulated Other Comprehensive Income——0USD—————
    Unclassified Non Current Assets————1,072,000USD———
    Other Assets———————1USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USD
    Total Assets98,726,000USD48,467,000USD46,080,000USD89,435,000USD137,174,000USD62,060,000USD42,485,000USD
    Other Current Assets2,106,000USD1,826,000USD2,937,000USD3,489,000USD3,338,000USD1,042,000USD310,000USD
    Total Liab286,488,000USD69,847,000USD8,145,000USD13,434,000USD27,474,000USD14,767,000USD13,099,000USD
    Total Stockholder Equity-187,762,000USD-21,380,000USD37,935,000USD76,001,000USD109,700,000USD47,293,000USD29,386,000USD
    Other Current Liab7,912,000USD5,180,000USD4,126,000USD6,848,000USD8,662,000USD3,394,000USD1,427,000USD
    Common Stock1,000USD——3,000USD4,000USD2,000USD1,000USD
    Capital Stock1,000USD0USD0USD3,000USD4,000USD2,000USD—
    Retained Earnings-527,285,000USD-285,259,000USD-221,695,000USD-178,653,000USD-142,649,000USD-88,001,000USD-55,285,000USD
    Cash89,245,000USD34,565,000USD36,043,000USD24,690,000USD33,091,000USD34,982,000USD29,104,000USD
    Cash And Short Term Investments89,245,000USD34,565,000USD36,043,000USD75,838,000USD101,851,000USD49,182,000USD29,104,000USD
    Total Current Assets91,559,000USD38,932,000USD41,132,000USD81,305,000USD105,189,000USD50,224,000USD29,414,000USD
    Total Current Liabilities9,930,000USD7,315,000USD7,148,000USD9,732,000USD13,573,000USD7,278,000USD3,900,000USD
    Net Debt-82,606,000USD-26,096,000USD-32,664,000USD-19,088,000USD-25,298,000USD-25,385,000USD-18,404,000USD
    Short Term Debt1,290,000USD1,829,000USD2,497,000USD2,226,000USD2,193,000USD2,108,000USD1,501,000USD
    Short Long Term Debt Total6,639,000USD8,469,000USD3,379,000USD5,602,000USD7,793,000USD9,597,000USD10,700,000USD
    Net Receivables208,000USD2,541,000USD2,152,000USD1,978,000USD0USD——
    Accounts Payable728,000USD306,000USD525,000USD658,000USD2,718,000USD1,776,000USD972,000USD
    Property Plant Equipment Net6,433,000USD8,363,000USD3,858,000USD6,898,000USD9,376,000USD11,392,000USD12,617,000USD
    Property Plant Equipment Gross14,808,000USD16,210,000USD11,226,000USD6,898,000USD9,376,000USD19,139,000USD—
    Common Stock Shares Outstanding7,478,000shares2,933,000shares2,017,999shares2,314,799shares2,335,628shares795,599shares393,311shares
    Non Current Assets Total7,167,000USD9,535,000USD4,948,000USD8,130,000USD31,985,000USD11,836,000USD13,071,000USD
    Non Current Liabilities Total276,558,000USD62,532,000USD997,000USD3,702,000USD13,901,000USD7,489,000USD9,199,000USD
    Non Current Liabilities Other158,662,000USD————6,914,162USD—
    Non Currrent Assets Other46,000USD1,172,000USD402,000USD1,232,000USD954,000USD444,000USD454,000USD
    Net Working Capital81,629,000USD31,617,000USD33,984,000USD71,573,000USD91,616,000USD42,946,000USD—
    Unclassified Non Current Liabilities117,896,000USD62,532,000USD—3,702,000USD5,600,000USD—9,199,000USD
    Unclassified Equity339,521,000USD263,879,000USD259,630,000USD254,889,000USD252,460,000USD135,290,000USD84,670,000USD
    Current Deferred Revenue——-1,171,000USD—8,073,000USD2,978,000USD—
    Short Term Investments——0USD51,148,000USD68,760,000USD14,200,000USD—
    Inventory——1USD————
    Long Term Investments———0USD21,655,000USD0USD—
    Accumulated Other Comprehensive Income———-241,000USD-119,000USD—0USD
    Other Liab————8,301,000USD——
    Other Assets————954,000USD444,000USD454,000USD
    Net Tangible Assets————109,700,000USD86,860,867USD-53,825,000USD
    Unclassified Current Liabilities————-8,073,000USD-2,978,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-127,505,000USD-183,159,000USD-71,643,000USD39,746,000USD-26,970,000USD-28,039,000USD-1,434,000USD-25,261,000USD
    Depreciation65,000USD45,000USD61,000USD137,000USD294,000USD322,000USD342,000USD386,000USD
    Stock Based Compensation2,105,000USD1,002,000USD1,005,000USD994,000USD834,000USD900,000USD1,039,000USD1,145,000USD
    Other Non Cash Items120,521,000USD171,945,000USD61,892,000USD-47,519,000USD17,939,000USD20,135,000USD-7,540,000USD17,178,000USD
    Change To Account Receivables-4,792,000USD2,081,999USD1,000USD250,000USD0USD9,498,000USD-10,000,000USD—
    Change In Working Capital-5,576,000USD4,355,000USD-355,000USD529,000USD-1,376,000USD10,163,000USD841,000USD941,000USD
    Total Cash From Operating Activities-12,495,000USD-5,812,000USD-9,040,000USD-6,113,000USD-9,279,000USD3,481,000USD-6,752,000USD-5,611,000USD
    Capital Expenditures-120,000USD-59,000USD-24,000USD-18,000USD-27,000USD-19,000USD0USD0USD
    Free Cash Flow-12,615,000USD-5,871,000USD-9,064,000USD-6,131,000USD-9,306,000USD3,462,000USD-6,752,000USD-5,611,000USD
    Total Cashflows From Investing Activities-120,000USD-59,000USD-24,000USD-18,000USD-27,000USD-19,000USD——
    Total Cash From Financing Activities30,280,000USD13,781,000USD9,000USD-5,124,000USD76,386,000USD91,000USD-1,000USD16,086,000USD
    Issuance Of Capital Stock26,858,000USD12,579,000USD0USD-5,185,000USD76,386,000USD0USD-1,000USD16,044,000USD
    Change In Cash17,665,000USD7,910,000USD-9,055,000USD-11,255,000USD67,080,000USD3,553,000USD-6,753,000USD10,475,000USD
    Begin Period Cash Flow89,245,000USD82,023,000USD91,078,000USD102,333,000USD35,253,000USD31,700,000USD38,453,000USD27,978,000USD
    End Period Cash Flow106,910,000USD89,933,000USD82,023,000USD91,078,000USD102,333,000USD35,253,000USD31,700,000USD38,453,000USD
    Other Cashflows From Financing Activities30,280,000USD13,781,000USD9,000USD——91,000USD-1,000USD42,000USD
    Unclassified Operating Cash Flow-2,105,000USD———————
    Unclassified Financing Cash Flow-26,858,000USD——-5,185,000USD————
    Sale Purchase Of Stock—137,000USD—61,000USD—95,000USD-1,000USD—
    Investments——-24,000USD-18,000USD-27,000USD-19,000USD0USD0USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USD
    Net Income-242,026,000USD-63,564,000USD-43,042,000USD-36,004,000USD-54,648,000USD-32,716,000USD-24,362,000USD
    Depreciation537,000USD1,442,000USD1,911,000USD1,955,000USD2,066,000USD1,937,000USD2,283,000USD
    Stock Based Compensation3,835,000USD4,114,000USD4,372,000USD4,517,000USD2,316,000USD635,000USD790,000USD
    Other Non Cash Items204,257,000USD41,216,000USD325,000USD-6,195,000USD1,674,000USD993,000USD1,300,000USD
    Change To Account Receivables2,333,000USD-502,000USD0USD-1,978,000USD0USD——
    Change In Working Capital3,153,000USD-836,000USD-3,929,000USD-8,418,000USD-221,000USD52,000USD-1,067,000USD
    Total Cash From Operating Activities-30,244,000USD-17,628,000USD-40,363,000USD-44,145,000USD-48,813,000USD-29,099,000USD-21,056,000USD
    Capital Expenditures-128,000USD-26,000USD-398,000USD-728,000USD-1,269,000USD-874,000USD-1,563,000USD
    Free Cash Flow-30,372,000USD-17,654,000USD-40,761,000USD-44,873,000USD-50,082,000USD-29,973,000USD-22,619,000USD
    Total Cashflows From Investing Activities-128,000USD-26,000USD51,723,000USD38,309,000USD-77,708,000USD-15,075,000USD-1,563,000USD
    Total Cash From Financing Activities85,052,000USD16,176,000USD276,000USD-2,565,000USD124,630,000USD50,052,000USD28,904,000USD
    Sale Purchase Of Stock198,000USD94,000USD-4,000USD-2,607,000USD-1,000USD-1,000USD-13,000USD
    Issuance Of Capital Stock83,780,000USD16,043,000USD0USD125,000USD124,220,000USD49,886,000USD—
    Change In Cash54,680,000USD-1,478,000USD11,636,000USD-8,401,000USD-1,891,000USD5,878,000USD29,509,000USD
    Begin Period Cash Flow35,253,000USD36,731,000USD25,095,000USD33,496,000USD35,387,000USD29,509,000USD—
    End Period Cash Flow89,933,000USD35,253,000USD36,731,000USD25,095,000USD33,496,000USD35,387,000USD29,509,000USD
    Other Cashflows From Financing Activities85,052,000USD133,000USD280,000USD42,000USD410,000USD50,052,000USD28,917,000USD
    Investments—-26,000USD44,136,000USD38,309,000USD-77,708,000USD-14,201,000USD-14,201,000USD
    Unclassified Financing Cash Flow—15,949,000USD——124,221,000USD48,387,000USD—
    Unclassified Investing Cash Flow——7,985,000USD-38,309,000USD77,708,000USD14,201,000USD14,201,000USD
    Other Cashflows From Investing Activities———39,037,000USD-76,439,000USD-14,201,000USD—
    Change To Liabilities————857,000USD537,000USD639,000USD
    Dividends Paid—————-48,386,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q1 2026Quarterly · 2026-03-31ProductCollaboration And License Revenue5,000,000USD0001193125-26-209179
    Q1 2026Quarterly · 2026-03-31ProductResearch Service Revenue0USD0001193125-26-209179
    FY 2025Yearly · 2025-12-31ProductCollaboration And License Revenue0USD0001193125-26-119818
    FY 2025Yearly · 2025-12-31ProductResearch Service Revenue3,477,000USD0001193125-26-119818
    Q3 2025Quarterly · 2025-09-30ProductCollaboration And License Revenue0USD0001193125-25-272422
    Q3 2025Quarterly · 2025-09-30ProductResearch Service Revenue983,000USD0001193125-25-272422
    Q1 2025Quarterly · 2025-03-31ProductCollaboration And License Revenue0USD0001193125-26-209179
    Q1 2025Quarterly · 2025-03-31ProductResearch Service Revenue983,000USD0001193125-26-209179
    FY 2024Yearly · 2024-12-31ProductCollaboration And License Revenue10,000,000USD0001193125-26-119818
    FY 2024Yearly · 2024-12-31ProductResearch Service Revenue655,000USD0001193125-26-119818
    Q3 2024Quarterly · 2024-09-30ProductCollaboration And License Revenue10,000,000USD0001193125-25-272422
    Q3 2024Quarterly · 2024-09-30ProductResearch Service Revenue0USD0001193125-25-272422

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.